The A2L intermediate gene product is required for in vitro transcription from a vaccinia virus late promoter.
Previously, the in vitro late transcription system of vaccinia virus was resolved into four components: the 17- and 30-kDa products of the A1L and G8R intermediate genes, respectively, the viral DNA-dependent RNA polymerase, and an unmapped factor sedimenting at 32 to 38 kDa. Another protein, the 26...
保存先:
| 出版年: | J Virol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1996
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC189821/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8523544/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.70.1.327-331.1996 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|